| HOME >> BIOLOGY >> TECHNOLOGY |
Figure III-1.6.2 Proportion of bio-pharmaceuticals market value in drug market, 2001-2007
Figure III-1.6.3 Proportion of anti-tumor monoclonal antibody market value in bio-pharmaceuticals market, 2007
Figure III-1.6.4 Rituximab market value in China, 2003-2008
Figure III-1.6.5 Trastuzumab market value in China, 2003-2008
Figure III-2.1 Geographical distribution of blood product manufacturers in China, 2009
Figure III-2.2 Output of human albumin in China, 2004-2009
Figure III-2.3 Average yield of human albumin in China, 2004-2008
Figure III-2.4 Number Changes in active human albumin producers, 2004-2009
Figure III-2.5 Human albumin market value in China, 2005-2009
Figure III-2.6 Lot release volume of imported human albumin, 2007-2009
Figure III-2.7 Forecast on human albumin output, 2010-2014
Figure III-2.8 Forecast on human albumin market value, 2010-2014
Figure III-3.1 Import and export situation of Chinese human vaccines, 2006-2009
Figure III-3.2 Vaccines import volume shares of import origins, 2009
Figure III-3.3 Market value of China's vaccine industry, 2006-2009
Figure III-3.4 Lot release volume of H1N1 Influenza A vaccine in China, 2009
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |